| 英文别名 |
HY-15689;Epacadostat;INCB-24360(INCB-024360);Epacadostat (INCB024360);IDO inhibitor 1;INCB024360;INCB-024360;INCB-24360;INCB 024360;Epacadostat(INCB 024360);AK174791;71596A9R13;N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-{[2-(sulfamoylamino)ethyl]amino}-1,2,5-oxadiazole-3-carboximidamide;Epacadostat [USAN:INN];Epacadostat; INCB024360;Epacadostat (JAN/USAN/INN);GTPL8221;FBKMWOJEPMPVTQ-UHFFFAOYSA-N;INCB 24360;BDBM222999;BCP1;Epacadostat/INCB024360;INCB24360;EPACADOSTAT [WHO-DD];BDBM532497;1,2,5-Oxadiazole-3-carboximidamide, 4-[[2-[(aminosulfonyl)amino]ethyl]amino]-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-, [C(Z)]-; [C(Z)]-4-[[2-[(Aminosulfonyl)amino]ethyl]amino]-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide; Epacadostat; ICBN 24360; INCB 024360;(3E)-3-[(3-bromo-4-fluoroanilino)-nitrosomethylidene]-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole;SCHEMBL18823200;DTXSID201318248;N-(3-Bromo-4-fluorophenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine;N-(3-Bromo-4-fluoro-phenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine;N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboximidamide;BCP14546;BRD-K79450420-001-01-8;Epacadostat (INCB024360)?;SCHEMBL145945;s7910;(Z)-N'-(3-BROMO-4-FLUOROPHENYL)-N-HYDROXY-4-{[2-(SULFAMOYLAMINO)ETHYL]AMINO}-1,2,5-OXADIAZOLE-3-CARBOXIMIDAMIDE;EPACADOSTAT [JAN];CCG-269104;AC-30226;AKOS032947327;NS00073353;(E)-N-(3-Bromo-4-fluorophenyl)-N'-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide;SCHEMBL19808101;AKOS025395427;BCP10561;1,2,5-Oxadiazole-3-carboximidamide, 4-((2-((aminosulfonyl)amino)ethyl)amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-, (C(Z))-;Q27077199;AKOS025404838;BDBM50126143;DS-8916;DB11717;DB-119064;(Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-(2-(sulfamoylamino)ethylamino)-1,2,5-oxadiazole-3-carboximidamide;1,2,5-OXADIAZOLE-3-CARBOXIMIDAMIDE, 4-((2-((AMINOSULFONYL)AMINO)ETHYL)AMINO)-N'-(3-BROMO-4-FLUOROPHENYL)-N-HYDROXY-;NSC785497;US11214554, Compound INCB024360;SCHEMBL25586672;1204669-58-8;EX-A793;EPACADOSTAT [INN];NCGC00402358-04;DS-015825;J-690060;(Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide;4-[[2-[(Aminosulfonyl)amino]ethyl]amino]-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide;4-({2-[(Aminosulfonyl)amino]ethyl}amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide;MFCD29075639;N'-(3-Bromo-4-fluorophenyl)-N-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide;(Z)-N-(3-Bromo-4-fluorophenyl)-N inverted exclamation mark -hydroxy-4-[[2-(sulfamoylamino)ethyl]amino]-1,2,5-oxadiazole-3-carboxamidine;1771804-57-9;SB19089;NCGC00421870-01;AKOS028109764;1,2,5-OXADIAZOLE-3-CARBOXIMIDAMIDE, 4-((2-((AMINOSULFONYL)... |